These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5091669)

  • 21. [Cases of hemophilia in the Karolinska Hospital Pediatric Clinic].
    Dohlwitz A
    Lakartidningen; 1968 Mar; 65(10):1033-6. PubMed ID: 5720701
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis C and pasteurised factor VIII and IX concentrates.
    Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
    Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trials of the recombinant factor VIII product, Kogenate.
    Inwood M; Lusher J
    Transfus Med Rev; 1992 Oct; 6(4):261-2. PubMed ID: 1421826
    [No Abstract]   [Full Text] [Related]  

  • 24. Ethical dilemmas in the pediatric hemophilia community.
    Schaefer J
    Pediatr Nurs; 1999; 25(5):537-9. PubMed ID: 12024403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of a new factor VIII concentrate in hemophilic children].
    Carnelli V; Cultrera S; Simoni L; Pasqui G; Busso B; Bagnato L
    Pediatr Med Chir; 1983; 5(3):49-55. PubMed ID: 6417627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of implantable venous access devices in children with severe hemophilia: benefits and burden.
    Van Dijk K; Van Der Bom JG; Bax KN; Van Der Zee DC; Van Den Berg MH
    Haematologica; 2004 Feb; 89(2):189-94. PubMed ID: 15003894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
    Thornburg CD; Pipe SW
    Haemophilia; 2006 Mar; 12(2):198-9. PubMed ID: 16476098
    [No Abstract]   [Full Text] [Related]  

  • 28. [A randomized in vivo trial of 3 factor VIII preparations].
    Jacobsen L; Clausen C; Jans H; Gormsen J
    Ugeskr Laeger; 1983 Mar; 145(10):739-42. PubMed ID: 6407165
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of treatment regimen with moroctocog alfa (AF-CC) on bleeding rates in paediatric patients with severe haemophilia A.
    Smith MP; Rupon J; Wali Y; Rimawi H; Korth-Bradley J; Smith L; Rendo P
    Haemophilia; 2020 Sep; 26(5):e232-e235. PubMed ID: 32497363
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prophylaxis in hemophilia].
    Ortega F; Martin-Villar J; Navarro JL
    Sangre (Barc); 1970; 15(3):355-61. PubMed ID: 5486763
    [No Abstract]   [Full Text] [Related]  

  • 31. Haemophilia care: from paediatrics to geriatrics. Introductory note.
    Oldenburg J; Salek SZ
    Haemophilia; 2009 Jan; 15 Suppl 1():1. PubMed ID: 19125933
    [No Abstract]   [Full Text] [Related]  

  • 32. Prophylaxis in haemophilia.
    Lancet; 1971 Jan; 1(7690):118-9. PubMed ID: 4099608
    [No Abstract]   [Full Text] [Related]  

  • 33. Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate.
    Mäkipernaa A; von Bonsdorff L
    Haemophilia; 2008 May; 14(3):612-4. PubMed ID: 18312362
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of factor VIII in hemophilia A patients assessed by frequency response method.
    Durisová M; Dedík L; Bátorová A; Sakalová A; Hedera J
    Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):217-26. PubMed ID: 9646284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of cryoprecipitate antihaemophilic factor for the treatment of haemophilia.
    Bloom AL; Emmanuel JH
    Q J Med; 1968 Apr; 37(146):291-302. PubMed ID: 5656159
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experience concerning substitution therapy of adult haemophiliacs in the Grisons (author's transl)].
    Hartmann S
    Ther Umsch; 1979 Apr; 36(4):301-6. PubMed ID: 451948
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate.
    Guérois C; Laurian Y; Rothschild C; Parquet-Gernez A; Duclos AM; Négrier C; Vicariot M; Fimbel B; Fressinaud E; Fiks-Sigaud M
    Thromb Haemost; 1995 Feb; 73(2):215-8. PubMed ID: 7792732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of urinary tract hemorrhage in a child with hemophilia A treated with cryoprecipitate AHG].
    Foltyn H; Wróbel I
    Pediatr Pol; 1969 Sep; 44(9):1155-7. PubMed ID: 5364502
    [No Abstract]   [Full Text] [Related]  

  • 40. Home infusion--the new approach.
    Vaugh E
    Health Care (Don Mills); 1980 Oct; 22(10):44, 46. PubMed ID: 10318526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.